• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】17443

【品名】(1R)-1-(1-naphthyl)ethylamine; (1R)-1-(1-naphthyl)-1-ethanamine

【CA登记号】3886-70-2

【 分 子 式 】C12H13N

【 分 子 量 】171.24196

【元素组成】C 84.17% H 7.65% N 8.18%

与该中间体有关的原料药合成路线共 7 条

合成路线1

该中间体在本合成路线中的序号:(XIV)

The condensation of diethyl succinate (IX) with benzaldehyde (II) gives 2-benzylidenesuccinic acid (III), which is treated with refluxing Ac2O to yield the corresponding anhydride (IV). Reaction of (IV) with cis-perhydroisoindole (V) in toluene affords the monoamide (VI), which is reduced with H2 over Pd/C in ethanol to provide the racemic benzylsuccinamic acid (X). Esterification of (X) with (S)-N-benzylmandelamide (XI) by means of DCC and DMAP in dichloromethane gives a mixture of diastereomeric esters, which were separated by column chromatography on silica gel to provide the desired diastereomer (XII). The hydrolysis of (XII) with NaOH in methanol yields the chiral acid (XIII), which is finally treated first with NaOH and then with CaCl2 in water. The preceding optical resolution of racemic acid (X) can also be performed with (R)-1-phenylethylamine (VII) or (R)-1-(1-naphthyl)ethylamine (XIV) by fractional crystallization of the corresponding diastereomeric salts and treatment with 2N HCl.

1 Castaner, R.M.; Sorbera, L.A.; Leeson, P.A.; Castaner, J.; Mitiglinide Calcium Hydrate. Drugs Fut 2000, 25, 10, 1034.
2 Yamaguchi, T.; et al.; Preparation of optically active succinic acid derivatives. I. Optical resolution of 2-benzyl-3-(cis-hexahydroisoindolin-2-ylcarbonyl)propionic acid. Chem Pharm Bull 1997, 45, 9, 1518.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(II) 10498 Benzaldehyde;Benzoic aldehyde;Phenylmethanal 100-52-7 C7H6O 详情 详情
(III) 41057 2-[(Z)-benzylidene]succinic acid C11H10O4 详情 详情
(IV) 41058 3-[(Z)-benzylidene]-2,5(4H)-furandione C11H8O3 详情 详情
(V) 41059 (3aR,7aS)octahydro-1H-isoindole C8H15N 详情 详情
(VI) 41060 (Z)-2-[2-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-oxoethyl]-3-phenyl-2-propenoic acid C19H23NO3 详情 详情
(VII) 10039 (1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine 3886-69-9 C8H11N 详情 详情
(IX) 12313 diethyl succinate 123-25-1 C8H14O4 详情 详情
(X) 41062 4-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-benzyl-4-oxobutyric acid C19H25NO3 详情 详情
(XI) 41063 (2S)-N-benzyl-2-hydroxy-2-phenylethanamide C15H15NO2 详情 详情
(XII) 41065 (1S)-2-(benzylamino)-2-oxo-1-phenylethyl (2S)-4-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-benzyl-4-oxobutanoate C34H38N2O4 详情 详情
(XIII) 41064 (2S)-4-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-benzyl-4-oxobutyric acid C19H25NO3 详情 详情
(XIV) 17443 (1R)-1-(1-naphthyl)ethylamine; (1R)-1-(1-naphthyl)-1-ethanamine 3886-70-2 C12H13N 详情 详情

合成路线2

该中间体在本合成路线中的序号:(XIV)

The optical resolution of racemic 2-benzylsuccinic acid (XV) using the chiral amines (R)-1-phenylethylamine (VII), (R)-1-(1-naphthyl)ethylamine (XIV) or (S)-1-phenyl-2-(4-tolyl)ethylamine (XVI) is carried out by fractional crystallization of the corresponding diastereomeric salts and treatment with 2N HCl, providing the desired enantiomer 2(S)-benzylsuccinic acid (XVII). Reaction of (XVII) with SOCl2 gives the corresponding acyl chloride (XVIII), which is treated with 4-nitrophenol (XIX) and TEA in dichloromethane to yield the activated diester (XX). The regioselective reaction of (XX) with cis-perhydroisoindole (V) in dichloromethane affords the monoamide (XXI), which by reaction with HCl and methanol provides the corresponding methyl ester (XXII). This ester is hydrolyzed with NaOH to the previously described chiral succinamic acid (XIII), which is finally converted into its calcium salt.

1 Castaner, R.M.; Sorbera, L.A.; Leeson, P.A.; Castaner, J.; Mitiglinide Calcium Hydrate. Drugs Fut 2000, 25, 10, 1034.
2 Mukaiyama, Y.; Hokari, H.; Kamijo, T.; Yanagi, T.; Yamaguchi, T.; Yamamoto, I.; Preparation of optically active succinic acid derivatives. II. Efficient and practical synthesis of KAD-1229. Chem Pharm Bull 1998, 46, 2, 337-340.
3 Yamaguchi, T.; et al.; Synthesis of KAD-1229, a succinic acid derivative with optical activity. 118th Annu Meet Pharmaceut Soc Jpn (March 31 1998, Kyoto) 1998, Abst 31(XP)9-9.
4 Yamaguchi, T.; Kamijo, T.; Yanagi, T. (Kissei Pharmaceutical Co., Ltd.); Process for producing optically active benzylsuccinic acid and intermediate therefor. WO 9832727 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(V) 41059 (3aR,7aS)octahydro-1H-isoindole C8H15N 详情 详情
(VII) 10039 (1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine 3886-69-9 C8H11N 详情 详情
(XIII) 41064 (2S)-4-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-benzyl-4-oxobutyric acid C19H25NO3 详情 详情
(XIV) 17443 (1R)-1-(1-naphthyl)ethylamine; (1R)-1-(1-naphthyl)-1-ethanamine 3886-70-2 C12H13N 详情 详情
(XV) 41066 2-benzylsuccinic acid C11H12O4 详情 详情
(XVI) 41067 (1S)-2-(4-methylphenyl)-1-phenylethylamine; (1S)-2-(4-methylphenyl)-1-phenyl-1-ethanamine 30339-30-1 C15H17N 详情 详情
(XVII) 41068 (2S)-2-benzylbutanedioic acid C11H12O4 详情 详情
(XVIII) 41069 (2S)-2-benzylbutanedioyl dichloride C11H10Cl2O2 详情 详情
(XIX) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(XX) 41070 bis(4-nitrophenyl) (2S)-2-benzylbutanedioate C23H18N2O8 详情 详情
(XXI) 41071 4-nitrophenyl (2S)-4-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-benzyl-4-oxobutanoate C25H28N2O5 详情 详情
(XXII) 41072 methyl (2S)-4-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-benzyl-4-oxobutanoate C20H27NO3 详情 详情

合成路线3

该中间体在本合成路线中的序号:(XXIX)

3) The condensation of 3-(trimethylsilyl)propynal (XXIII) with the dialkaline salt of ethylacetoacetate (XXIV) in THF gives 5-hydroxy-3-oxo-7-(trimethylsilyl)-6-heptynoic acid ethyl ester (XXV), which is reduced with NaBH4/diethylmethoxyborane to the racemic 3,5-dihydroxy-7-(trimethylsilyl)-6-heptynoic acid ethyl ester (XXVI). The protection and desilylation of (XXVI) with 2,2-dimethoxypropane and p-toluenesulfonic acid yields the protected heptynoic ester (XXVII), which is saponified to the corresponding acid (XXVIII) with NaOH. The optical resolution of the racemic acid (XXVIII) by treatment with 1(R)-(1-naphthyl)ethylamine (XXIX) and crystallization of the diastereomeric salts affords the protected (3R,5S)-isomer (XXX), which is esterified with ethyl iodide and DBU to the corresponding ester (XXXI). The condensation of (XXXI) with 2-cyclopropyl-4-(4-fluorophenyl)-3-iodoquinoline (XXI, see Scheme 5) by means of disiamylborane, NaOEt and PdCl2 in acetonitrile gives the protected (3R,5S)-NK-104 ethyl ester (XXXII).

1 Castaner, J.; Sorbera, L.A.; Leeson, P.A.; NK-104. Drugs Fut 1998, 23, 8, 847-859.
2 Iwasaki, H.; Miyachi, N.; Yanagawa, Y.; Ohara, Y.; Hiyama, T.; A novel synthetic method of HMG-CoA reductase inhibitor NK-104 via a hydroboration-cross-coupling sequence. Tetrahedron Lett 1993, 34, 51, 8267-70.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXI) 17435 2-cyclopropyl-4-(4-fluorophenyl)-3-iodoquinoline C18H13FIN 详情 详情
(XXIII) 17437 2-butynal C4H4O 详情 详情
(XXIV) 17438 lithium sodium (1E)-1-ethoxy-1,3-butadiene-1,3-diolate C6H8LiNaO3 详情 详情
(XXV) 17439 ethyl 5-hydroxy-3-oxo-7-(trimethylsilyl)-6-heptynoate C12H20O4Si 详情 详情
(XXVI) 17440 ethyl 3,5-dihydroxy-7-(trimethylsilyl)-6-heptynoate C12H22O4Si 详情 详情
(XXVII) 17441 ethyl 2-(6-ethynyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate C12H18O4 详情 详情
(XXVIII) 17442 2-(6-ethynyl-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid C10H14O4 详情 详情
(XXIX) 17443 (1R)-1-(1-naphthyl)ethylamine; (1R)-1-(1-naphthyl)-1-ethanamine 3886-70-2 C12H13N 详情 详情
(XXX) 17444 2-[(4R,6S)-6-ethynyl-2,2-dimethyl-1,3-dioxan-4-yl]acetic acid C10H14O4 详情 详情
(XXXI) 17445 ethyl 2-[(4R,6S)-6-ethynyl-2,2-dimethyl-1,3-dioxan-4-yl]acetate C12H18O4 详情 详情
(XXXII) 17446 ethyl 2-((4R,6S)-6-[(E)-2-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]ethenyl]-2,2-dimethyl-1,3-dioxan-4-yl)acetate C30H32FNO4 详情 详情

合成路线4

该中间体在本合成路线中的序号:(XXIX)

Reaction of chloroacetic acid (XXII) with sodium ethoxide (XXIII) in ethanol gives 2-ethoxyacetic acid ethyl ester (XXIV), which is condensed with 4-methoxybenz-aldehyde (XXV) by means of t-BuOK in THF to yield 2-ethoxy-3-(4-methoxyphenyl)-2-propenoic acid ethyl ester (XXVI). Hydrolysis of ester (XXVI) with NaOH in hot ethanol/water affords the propenoic acid derivative (XXVII), which is reduced with H2 over Pd/C in ethanol to provide racemic 2-ethoxy-3-(4-methoxyphenyl)propionic acid (XXVIII). Optical resolution of mixture (XXVIII) is performed by salt formation with 1(S)-(1-naphthyl)ethylamine (XXIX) followed by crystallization to give the diastereomeric salt (XXX), which is treated with NaOH, followed by acidification with HCl to yield 2(S)-ethoxy-3-(4-methoxyphenyl)propionic acid (XXXI). Demethylation of compound (XXXI) by reaction with NaOH and octanethiol in NMP affords 2(S)-ethoxy-3-(4-hydroxyphenyl)propionic acid (XXXII), which is esterified with ethanol/HCl to provide the corresponding ethyl ester (XXXIII). Condensation of ester (XXXIII) with the bismesylate (II) by means of either K2CO3 in 2-butanone or Na2CO3 in acetone provides 2(S)-ethoxy-3-[4-[2-[4-(methanesulfonyloxy)-phenyl]ethoxy]phenyl]propionic acid ethyl ester (XXI), which is finally hydrolyzed with NaOH or LiOH in acetone/water.

1 McIntyre, J.A.; Castaner, J.; Bayes, M.; Tesaglitazar. Drugs Fut 2003, 28, 10, 959.
2 Ioannidis, P.; Ehrl, R.; MacKintosh, W. (AstraZeneca AB); Process for the preparation 3-aryl-2-hydroxypropionic acid deriv.. WO 0296865 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(II) 50403 4-[2-[(methylsulfonyl)oxy]ethyl]phenyl methanesulfonate C10H14O6S2 详情 详情
(XX) 50418 ethyl (2S)-2-ethoxy-3-(4-hydroxyphenyl)propanoate C13H18O4 详情 详情
(XXI) 50419 ethyl (2S)-2-ethoxy-3-[4-([4-[(methylsulfonyl)oxy]phenethyl]oxy)phenyl]propanoate C22H28O7S 详情 详情
(XXII) 11847 2-Chloroacetic acid; Chloroacetic Acid 79-11-8 C2H3ClO2 详情 详情
(XXIII) 63048 sodium 1-ethanolate C2H5NaO 详情 详情
(XXIV) 63049 ethyl 2-ethoxyacetate C6H12O3 详情 详情
(XXV) 27251 4-methoxybenzaldehyde; Anisicaldehyde; p-anisaldehyde 123-11-5 C8H8O2 详情 详情
(XXVI) 63050 ethyl (E)-2-ethoxy-3-(4-methoxyphenyl)-2-propenoate C14H18O4 详情 详情
(XXVII) 63051 (E)-2-ethoxy-3-(4-methoxyphenyl)-2-propenoic acid C12H14O4 详情 详情
(XXVIII) 63052 2-ethoxy-3-(4-methoxyphenyl)propanoic acid C12H16O4 详情 详情
(XXIX) 17443 (1R)-1-(1-naphthyl)ethylamine; (1R)-1-(1-naphthyl)-1-ethanamine 3886-70-2 C12H13N 详情 详情
(XXX) 63053 (1S)-1-(1-naphthyl)-1-ethanaminium (2S)-2-ethoxy-3-(4-methoxyphenyl)propanoate C24H29NO4 详情 详情
(XXXI) 63054 (2S)-2-ethoxy-3-(4-methoxyphenyl)propanoic acid C12H16O4 详情 详情
(XXXII) 63055 (2S)-2-ethoxy-3-(4-hydroxyphenyl)propanoic acid C11H14O4 详情 详情

合成路线5

该中间体在本合成路线中的序号:(I)

Reaction of 1(R)-(1-naphthyl)ethylamine (I) with 3-[3-(trifluoromethyl)phenyl]propionaldehyde (II) by means of titanium tetraisopropoxide gives the corresponding imine (III), which is finally reduced with NaBH3CN in ethanol.

1 Bayes, M.; Castaner, R.M.; Sorbera, L.A.; Cinacalcet Hydrochloride. Drugs Fut 2002, 27, 9, 831.
2 Moe, S.T.; Balandrin, M.F.; Van Wagenen, B.C.; Nemeth, E.F.; DelMar, E.G. (NPS Pharmaceuticals, Inc.); Calcium receptor-active cpds.. US 6211244 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 17443 (1R)-1-(1-naphthyl)ethylamine; (1R)-1-(1-naphthyl)-1-ethanamine 3886-70-2 C12H13N 详情 详情
(II) 55375 3-[3-(trifluoromethyl)phenyl]propanal C10H9F3O 详情 详情
(III) 55376 N-[(1R)-1-(1-naphthyl)ethyl]-N-{(E)-3-[3-(trifluoromethyl)phenyl]propylidene}amine; (1R)-1-(1-naphthyl)-N-{(E)-3-[3-(trifluoromethyl)phenyl]propylidene}-1-ethanamine C22H20F3N 详情 详情

合成路线6

该中间体在本合成路线中的序号:(III)

 

1 Van Wagenen BC.Moe ST,et aL 2001.Pteparationof l-arldethyttunines as.calcium receptor ligands US 6211244
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 66202 3-(3-TRIFLUOROMETHYL-PHENYL)-PROPIONITRILE 95096-06-3 C10H8F3N 详情 详情
(II) 66203 (E)-di-tert-butyl((3-(3-(trifluoromethyl)phenyl)propylidene)amino)aluminum   C18H27AlF3N 详情 详情
(III) 17443 (1R)-1-(1-naphthyl)ethylamine; (1R)-1-(1-naphthyl)-1-ethanamine 3886-70-2 C12H13N 详情 详情
(IV) 55376 N-[(1R)-1-(1-naphthyl)ethyl]-N-{(E)-3-[3-(trifluoromethyl)phenyl]propylidene}amine; (1R)-1-(1-naphthyl)-N-{(E)-3-[3-(trifluoromethyl)phenyl]propylidene}-1-ethanamine C22H20F3N 详情 详情

合成路线7

该中间体在本合成路线中的序号:(VII)

 

1 Lifshitz Liron R. Eisenstadt A, et aL 2006. Process for preparing cinacalcet from 3-(3-trifluoromethylphenyl) propanol. W0 2006125026
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(V) 66204 3-(3-(trifluoromethyl)phenyl)propan-1-ol   C10H11F3O 详情 详情
(I) 26348 1-bromo-3-(trifluoromethyl)benzene; 3-Bromobenzotrifluoride 401-78-5 C7H4BrF3 详情 详情
(II) 10164 ethyl acrylate 140-88-5 C5H8O2 详情 详情
(III) 42936 ethyl (E)-3-[3-(trifluoromethyl)phenyl]-2-propenoate 113048-68-3 C12H11F3O2 详情 详情
(IV) 42937 (E)-3-[3-(trifluoromethyl)phenyl]-2-propen-1-ol C10H9F3O 详情 详情
(VI) 66205 3-(3-(trifluoromethyl)phenyl)propyl methanesulfonate   C11H13F3O3S 详情 详情
(VII) 17443 (1R)-1-(1-naphthyl)ethylamine; (1R)-1-(1-naphthyl)-1-ethanamine 3886-70-2 C12H13N 详情 详情
Extended Information